941 related articles for article (PubMed ID: 26090067)
41. Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana.
Mutocheluh M; Owusu M; Kwofie TB; Akadigo T; Appau E; Narkwa PW
BMC Res Notes; 2014 Dec; 7():873. PubMed ID: 25475050
[TBL] [Abstract][Full Text] [Related]
42. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation.
Heim A; Wagner D; Rothämel T; Hartmann U; Flik J; Verhagen W
J Med Virol; 1999 Jul; 58(3):291-5. PubMed ID: 10447426
[TBL] [Abstract][Full Text] [Related]
44. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
[TBL] [Abstract][Full Text] [Related]
45. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
Martin LA; Stramer SL; Kuhns MC; Schlauder GG
Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of blood donors questionnaire in a developing country: The case of Gabon.
Kouegnigan Rerambiah L; Biyoghe AS; Bengone C; Djoba Siawaya JF
Transfus Clin Biol; 2014 Jun; 21(3):116-9. PubMed ID: 24811564
[TBL] [Abstract][Full Text] [Related]
47. [Comparative sensitivity of different solid-phase immunoassays for detecting HBsAg and anti-HCV in blood].
León P; López JA; Domingo CJ; Echevarría JM
Sangre (Barc); 1992 Oct; 37(5):407-10. PubMed ID: 1284096
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
49. Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Syphilis among Blood Donors at Jigjiga Blood Bank, Eastern Ethiopia.
Abate M; Wolde T
Ethiop J Health Sci; 2016 Mar; 26(2):153-60. PubMed ID: 27222628
[TBL] [Abstract][Full Text] [Related]
50. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
51. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
52. Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda.
Butler EK; McCullough J
Transfusion; 2018 Apr; 58(4):854-861. PubMed ID: 29405306
[TBL] [Abstract][Full Text] [Related]
53. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
[TBL] [Abstract][Full Text] [Related]
54. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
Nübling CM; Chudy M; Volkers P; Löwer J
Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
[TBL] [Abstract][Full Text] [Related]
55. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation.
Okoroiwu HU; Okafor IM; Asemota EA; Okpokam DC
BMC Public Health; 2018 May; 18(1):645. PubMed ID: 29788937
[TBL] [Abstract][Full Text] [Related]
56. Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.
Amarapurkar DN; Kumar A; Vaidya S; Murti P; Bichile SK; Kalro RH; Desai HG
Indian J Gastroenterol; 1992 Apr; 11(2):80-1. PubMed ID: 1428037
[TBL] [Abstract][Full Text] [Related]
57. [Seroprevalence of markers of transfusion transmissible infections in blood bank in Colombia].
Bedoya JA; Cortés Márquez MM; Cardona Arias JA
Rev Saude Publica; 2012 Dec; 46(6):950-9. PubMed ID: 23503536
[TBL] [Abstract][Full Text] [Related]
58. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria.
Opaleye OO; Igboama MC; Ojo JA; Odewale G
J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258
[TBL] [Abstract][Full Text] [Related]
59. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands.
van Hulst M; Hubben GA; Sagoe KW; Promwong C; Permpikul P; Fongsatitkul L; Glynn DM; Sibinga CT; Postma MJ
Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093
[TBL] [Abstract][Full Text] [Related]
60. Seroprevalence and associated risk factors for HIV, Hepatitis B and C among blood Donors in South Gondar District blood Bank, Northwest Ethiopia.
Negash M; Ayalew M; Geremew D; Workineh M
BMC Infect Dis; 2019 May; 19(1):430. PubMed ID: 31096921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
